A Multicenter, Prospective, Observational, Real-World Registry Study of Cenobamate in the Treatment of Focal Epilepsy (ChiCTR) - Oct 16, 2026 - P4 | N=1000 | Not yet recruiting | Sponsor: Beijing Tiantan Hospital, Capital Medical University; Beijing Tiantan Hospital, Capital Medical University
New P4 trial • CNS Disorders • Epilepsy
|